• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.

作者信息

Petroff David, Blüher Matthias, Wiegand Johannes

机构信息

Clinical Trial Center, University of Leipzig, Leipzig, Germany; IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.

Department of Medicine, Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany; IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.

出版信息

Dig Liver Dis. 2018 Jul;50(7):731-733. doi: 10.1016/j.dld.2018.03.029. Epub 2018 Mar 30.

DOI:10.1016/j.dld.2018.03.029
PMID:29699861
Abstract
摘要

相似文献

1
Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.德国肥胖学会成员对德国以及欧洲肝脏研究学会（EASL）、欧洲糖尿病研究学会（EASD）和欧洲肥胖研究学会（EASO）非酒精性脂肪性肝病指南的了解与实践情况。
Dig Liver Dis. 2018 Jul;50(7):731-733. doi: 10.1016/j.dld.2018.03.029. Epub 2018 Mar 30.
2
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?EASL-EASD-EASO 临床实践指南：严重肥胖人群非酒精性脂肪性肝病的管理——是否导致过度转诊？
Diabetologia. 2017 Jul;60(7):1218-1222. doi: 10.1007/s00125-017-4264-9. Epub 2017 Mar 28.
3
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南：普遍筛查是否合适？
Diabetologia. 2016 Jun;59(6):1141-4. doi: 10.1007/s00125-016-3910-y. Epub 2016 Apr 7.
4
[Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016].[非酒精性脂肪性肝病——基于2016年欧洲肝脏研究学会（EASL）、欧洲糖尿病研究学会（EASD）和欧洲肥胖研究学会（EASO）临床实践指南的总结与更新]
Orv Hetil. 2018 Nov;159(45):1815-1830. doi: 10.1556/650.2018.31231.
5
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD.不同肝纤维化生物标志物对严重肥胖和非酒精性脂肪性肝病患者肝科转诊的影响。
J Endocrinol Invest. 2020 Jul;43(7):1019-1026. doi: 10.1007/s40618-020-01188-7. Epub 2020 Feb 1.
6
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016.2 型糖尿病中非酒精性脂肪肝疾病的筛查策略：来自 NHANES 2005-2016 的见解。
Diabetes Res Clin Pract. 2020 Sep;167:108358. doi: 10.1016/j.diabres.2020.108358. Epub 2020 Jul 31.
7
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes.欧洲肝脏研究学会（EASL）、欧洲糖尿病研究学会（EASD）和欧洲肥胖研究学会（EASO）非酒精性脂肪性肝病管理临床实践建议：评估其在 2 型糖尿病患者中的应用。
Diabet Med. 2018 Mar;35(3):368-375. doi: 10.1111/dme.13565. Epub 2018 Jan 10.
8
Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.罗马尼亚非酒精性脂肪性肝病/非酒精性脂肪性肝炎的真实感知和实践模式：102 名经董事会认证的胃肠病学家完成的调查结果。
J Gastrointestin Liver Dis. 2016 Jun;25(2):183-9. doi: 10.15403/jgld.2014.1121.252.naf.
9
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
10
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease.过度医疗：非酒精性脂肪性肝病的过度诊断和过度治疗。
Lancet Gastroenterol Hepatol. 2018 Jan;3(1):66-72. doi: 10.1016/S2468-1253(17)30142-5.

引用本文的文献

1
Metabolic dysfunction associated steatotic liver disease-Clinicians should not underestimate the role of steatosis.代谢功能障碍相关脂肪性肝病——临床医生不应低估脂肪变性的作用。
United European Gastroenterol J. 2024 Apr;12(3):277-278. doi: 10.1002/ueg2.12520. Epub 2024 Jan 4.
2
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination.现行的非酒精性脂肪性肝病（NAFLD）指南用于糖尿病患者的风险分层诊断准确性较差。
Sci Rep. 2020 Oct 27;10(1):18345. doi: 10.1038/s41598-020-75227-x.